Antihypertensive treatments and risks of lung Cancer: a large population-based cohort study in Hong Kong.

BACKGROUND: There is a growing concern that the use of anti-hypertensives may be associated with an increased risk of cancer, but it remains uncertain for the association between anti-hypertensives and lung cancer risk, as well as their interaction with aspirin in chemoprotective effects. METHODS: The goal of this study is to assess the association between anti-hypertensives use and the risk of lung cancer, as well as the chemopreventive impacts from the combination usage of aspirin and anti-hypertensives. A retrospective cohort study was conducted based on all the public hospital electronic medical records in Hong Kong. Patients with prescription records of anti-hypertensives (ACEi/ARB, CCB, ß-blocker,α-blocker) and/or aspirin were included as the exposure groups. Using the Cox proportional hazards model with inverse probability weighting, we estimated hazard ratios (HRs) with 95% confidence intervals (CIs) for lung cancer risk from anti-hypertensives usage or combination usage of aspirin with anti-hypertensives. The likelihood ratio test and interaction model were adopted for exploring the interaction effects with aspirin. RESULTS: A total of 6592 and 84,116 lung cancer cases were identified from the groups of anti-hypertensives users and anti-hypertensives users with aspirin, respectively. The group of non-aspirin patients who received anti-hypertensives showed a significantly lower risk of lung cancer (HR: 0.63, 95% CI: 0.60-0.66), compared to those without anti-hypertensives. When aspirin and α-blocker were used simultaneously, it could lower the risk of lung cancer significantly (HR: 0.53, 95% CI: 0.34-0.84). Moreover, the lower risk of lung cancer persisted with a longer follow-up period of anti-hypertensives usage. Combination usage with aspirin in the users of ACEi/ARB, CCB, and α-blocker showed significant interaction effects. However, the smoking effect could not be eliminated in this analysis. DISCUSSION: Anti-hypertensive treatment was associated with a lower risk of lung cancer, which is associated with the anti-hypertensives exposure period. The potential interaction on the chemopreventive influence from combination usage of α-blocker and aspirin might exist. More corroborations on these findings are needed to focus on the different settings in future studies.

Learning Curve in Monitoring Magnetically Controlled Growing Rod Distractions With Ultrasound.

STUDY DESIGN: Prospective study. OBJECTIVE: To determine whether a learning curve exists for ultrasound measurement of magnetically controlled growing rod (MCGR) distractions. SUMMARY OF BACKGROUND DATA: For patients managed by MCGRs, close monitoring of interval distraction length gains is important to determine whether the distractions are translating into actual spine growth. Radiographs are the criterion standard for measuring length gains, but ultrasound has been shown to be effective in monitoring distraction lengths without radiation exposure. It is, however, an operator-dependent tool and thus the accuracy of ultrasound measurement of distracted length may improve with experience. METHODS: This is a prospective correlation analysis of patients who underwent MCGR treatment for scoliosis. The study period was inclusive of 19th February 2013 to 31st March 2015. All subjects were consecutively recruited in a prospective manner. Data regarding date of the distraction visit, and the interval radiograph and ultrasound measurements of the distracted lengths were collected. Only those episodes with both radiograph and ultrasound performed were used for analysis. The mean differences in change of radiograph and ultrasound measurements were plotted to determine correlation differences and to observe for a learning curve. RESULTS: A total of 379 distraction episodes were analyzed. The mean differences between ultrasound and radiograph measurements per distraction episode were -0.3 mm for the right rod and -0.1 mm for the left rod. For learning curve analysis, there were three distinct timepoints in which the difference of correlation became significantly better and were described as clusters. The correlation in the first cluster (19th February 2013 to 15th October 2013) was 0.612 (right rod) and 0.795 (left rod), the second cluster (16th October 2013 to 20th May 2014) was 0.879 (right rod) and 0.918 (left rod), and the third cluster (21st May 2014 to 31st March 2015) was 0.956 (right rod) and 0.932 (left rod). Thus, a plateau was observed at the second cluster, which translated to 97 to 146 rod measurements. CONCLUSION: Correlation between radiograph and ultrasound measurements is reasonable to begin with but improves with time. During initial use, successful distractions should correlate between the clinical feel and ultrasound confirmation. Although the absolute value may not be accurate and may require radiographs to confirm, with time and experience, ultrasound measurements can then be more reliable. LEVEL OF EVIDENCE: 3.

Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B.

BACKGROUND AND AIMS: The proposed cut-off values for the degree of fibrosis as assessed by liver stiffness measurement (LSM) might not be applicable in severe acute exacerbation of chronic hepatitis B (CHB). We aimed to assess the effect of necroinflammatory activity on LSM in this condition. METHODS: We prospectively recruited consecutive patients with severe acute exacerbation of CHB (alanine aminotransferase or ALT > 10x upper limit of normal). The relationship of ALT levels and LSM were serially assessed and liver biopsy was carried out after ALT normalization. RESULTS: Eleven patients (10 male, median age 43 years) were followed up for 25 weeks; nine patients received antiviral therapy. Overall, LSM was positively correlated with ALT levels (r = 0.67, P < 0.001). At initial presentation, the median serum ALT and LSM was 1136 (581-2210) IU/L and 26.3 (11.1-33.3) kPa. A progressive reduction in LSM was observed during subsequent visits in parallel with the reduction of ALT levels. At the last visit, the median ALT was 27 (11-52) IU/L and LSM was 7.7 (4.7-10.8) kPa. Among the five patients who had liver biopsy carried out at week 25, four patients had F2 fibrosis (LSM 5.7-8.1 kPa) and one patient had F3 fibrosis (LSM 8.6 kPa). CONCLUSIONS: LSM using transient elastography with the current proposed cut-off values might misdiagnose liver cirrhosis in patients suffering from severe acute exacerbation of CHB. LSM should be assessed after normalization of ALT levels in order to accurately assess the degree of fibrosis.